Stefanie Robert

'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.

Clinical medicine August 1, 2014 Christopher D Smith, Stefanie Robert

The use of novel psychoactive substances ('legal highs' or 'designer drugs') is increasing worldwide. Patients misusing such substances have been reported to experience severe or prolonged side effects requiring admission to acute or critical care wards. These complications can be life threatening if misdiagnosed or mismanaged. As physicians have traditionally had less involvement with the...